Remove 2013 Remove Chemotherapy Remove Labelling
article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

How do you perceive radiopharmaceuticals complementing existing cancer treatments, such as chemotherapy and immunotherapy? There is great hope of this class of drug specifically to work in conjunction with immunotherapeutics, given the lack of toxicity of radiopharmaceuticals in general compared to most chemotherapies.

article thumbnail

Selenium: The Nutrient That Can Reduce Thyroid Antibodies by 40%

The Thyroid Pharmacist

In one study done in 2013, patients with autoimmune thyroiditis were split into two groups, with one group being treated with 600 mg of myo-inositol and 83 mcg of selenium (selenomethionine) per day for 6 months, and the other being treated with just 83 mcg of selenium. doi:10.1155/2013/424163. doi:10.1155/2013/424163.

Dosage 59
article thumbnail

How to Lose Weight With Hashimoto’s

The Thyroid Pharmacist

A 2013 study explored the effects of myo-inositol and D-chiro-inositol supplementation on metabolic health in individuals with PCOS. [3] doi:10.7860/JCDR/2013/6518.3306 [2] Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, et al. 2013 Feb;17(4):537-40. [4] 17] In my experience, Zyprexa was the worst offender. J Clin Diagn Res.